Evidence map›Paper›PMID 25194019›Full record

ReviewThe Journal of pharmacology and experimental therapeutics2014

Stress-induced pain: a target for the development of novel therapeutics.

Anthony C Johnson, Beverley Greenwood-Van Meerveld

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of pharmacology and experimental therapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Design, Synthesis, andACS omega · 2024
    Article
  5. Reproducible microbiome composition signatures of anxiety and depressive symptoms.Computational and structural biotechnology journal · 2023
    Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Complementary and alternative medicine therapies for chronic pain.Chinese journal of integrative medicine · 2016
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Could Stress Contribute to Pain-Related Fear in Chronic Pain?Frontiers in behavioral neuroscience · 2015
    Article
  20. The janus face of stress on reproduction: from health to disease.International journal of endocrinology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anthony C JohnsonVeterans Affairs Medical Center (B.G.-V.M.), Department of Physiology (B.G.-V.M.), and Oklahoma Center for Neuroscience (A.C.J., B.G.-V.M.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Beverley Greenwood-Van MeerveldVeterans Affairs Medical Center (B.G.-V.M.), Department of Physiology (B.G.-V.M.), and Oklahoma Center for Neuroscience (A.C.J., B.G.-V.M.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma Beverley-Greenwood@ouhsc.edu.
University of Oklahoma Health Sciences Center · US

Funding

Central Molecular Mechanisms of Stress-Induced Visceral HypersensitivityF31DK089871 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JOHNSON, ANTHONY C · 2010 to 2012
$77k
Central Mechanisms Modulating Visceral SensitivityI01BX002188 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI HOUCHEN, COURTNEY WAYNE · 2013 to 2022
–
BLRD VA I01 BX002188NIDDK NIH HHS F31 DK089871NIDDK NIH HHS F31-DK089871
6 · The paper itself

Abstract

Although current therapeutics provide relief from acute pain, drugs used for treatment of chronic pain are typically less efficacious and limited by adverse side effects, including tolerance, addiction, and gastrointestinal upset. Thus, there is a significant need for novel therapies for the treatment of chronic pain. In concert with chronic pain, persistent stress facilitates pain perception and sensitizes pain pathways, leading to a feed-forward cycle promoting chronic pain disorders. Stress exacerbation of chronic pain suggests that centrally acting drugs targeting the pain- and stress-responsive brain regions represent a valid target for the development of novel therapeutics. This review provides an overview of how stress modulates spinal and central pain pathways, identifies key neurotransmitters and receptors within these pathways, and highlights their potential as novel targets for therapeutics to treat chronic pain.

Indexed as

Analgesics, OpioidAnimalsBrainChronic PainHumansNeurotransmitter AgentsNociceptorsStress, PsychologicalAnalgesics, OpioidNeurotransmitter Agents

Identifiers

PMID25194019
PMCPMC4201269
OpenAlexW2138206568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.